ID28650A - KOMPOSISI FARMASI BERDASARKAN PADA α-SIKLODEKSTRIN UNTUK PENGGUNAAN SECARA DIMAKAN DARI ANALOG LH-RH - Google Patents

KOMPOSISI FARMASI BERDASARKAN PADA α-SIKLODEKSTRIN UNTUK PENGGUNAAN SECARA DIMAKAN DARI ANALOG LH-RH

Info

Publication number
ID28650A
ID28650A IDW20010683A ID20010683A ID28650A ID 28650 A ID28650 A ID 28650A ID W20010683 A IDW20010683 A ID W20010683A ID 20010683 A ID20010683 A ID 20010683A ID 28650 A ID28650 A ID 28650A
Authority
ID
Indonesia
Prior art keywords
cycododstrine
analogue
pharmaceutical composition
composition based
eating use
Prior art date
Application number
IDW20010683A
Other languages
English (en)
Indonesian (id)
Inventor
Delansorne Remi
Bonnet Paule
Paris Jacques
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of ID28650A publication Critical patent/ID28650A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
IDW20010683A 1998-09-30 1999-09-23 KOMPOSISI FARMASI BERDASARKAN PADA α-SIKLODEKSTRIN UNTUK PENGGUNAAN SECARA DIMAKAN DARI ANALOG LH-RH ID28650A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues

Publications (1)

Publication Number Publication Date
ID28650A true ID28650A (id) 2001-06-21

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010683A ID28650A (id) 1998-09-30 1999-09-23 KOMPOSISI FARMASI BERDASARKAN PADA α-SIKLODEKSTRIN UNTUK PENGGUNAAN SECARA DIMAKAN DARI ANALOG LH-RH

Country Status (28)

Country Link
EP (2) EP0998940A1 (cs)
JP (1) JP4485060B2 (cs)
KR (1) KR100652457B1 (cs)
CN (1) CN1200727C (cs)
AR (1) AR023056A1 (cs)
AT (1) ATE218358T1 (cs)
AU (1) AU756233B2 (cs)
BR (1) BR9914125A (cs)
CA (1) CA2344470C (cs)
CZ (1) CZ302343B6 (cs)
DE (1) DE69901721T2 (cs)
DK (1) DK1117420T3 (cs)
EE (1) EE04872B1 (cs)
ES (1) ES2178478T3 (cs)
HK (1) HK1042047B (cs)
HU (1) HUP0103649A3 (cs)
ID (1) ID28650A (cs)
IL (2) IL142112A0 (cs)
MX (1) MXPA01003340A (cs)
NO (1) NO330234B1 (cs)
NZ (1) NZ510446A (cs)
PL (1) PL200693B1 (cs)
PT (1) PT1117420E (cs)
RU (1) RU2214270C2 (cs)
SI (1) SI1117420T1 (cs)
TR (1) TR200100887T2 (cs)
WO (1) WO2000018423A1 (cs)
ZA (1) ZA200102452B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)
WO2024210903A1 (en) * 2023-04-07 2024-10-10 Najib Lamharzi Modified peptide ligands for stable delivery of highly potent payloads to tumors: method of making and using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
WO1997021448A1 (en) * 1995-12-13 1997-06-19 Dullatur Limited A calcitonin preparation
EP0839525B1 (en) * 1996-10-31 2004-08-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EE200100196A (et) 2002-06-17
ZA200102452B (en) 2002-03-26
MXPA01003340A (es) 2004-04-21
KR20010075255A (ko) 2001-08-09
ES2178478T3 (es) 2002-12-16
NO20011576D0 (no) 2001-03-28
AR023056A1 (es) 2002-09-04
SI1117420T1 (en) 2002-12-31
CZ20011173A3 (cs) 2001-09-12
RU2214270C2 (ru) 2003-10-20
WO2000018423A1 (en) 2000-04-06
AU6199999A (en) 2000-04-17
BR9914125A (pt) 2001-06-19
DE69901721T2 (de) 2003-01-09
EP0998940A1 (en) 2000-05-10
HUP0103649A3 (en) 2002-05-28
PL200693B1 (pl) 2009-01-30
JP2002525336A (ja) 2002-08-13
IL142112A (en) 2006-10-31
CA2344470C (en) 2009-01-06
EP1117420B1 (en) 2002-06-05
DE69901721D1 (de) 2002-07-11
AU756233B2 (en) 2003-01-09
ATE218358T1 (de) 2002-06-15
IL142112A0 (en) 2002-03-10
KR100652457B1 (ko) 2006-11-30
CN1200727C (zh) 2005-05-11
PL346939A1 (en) 2002-03-11
NO20011576L (no) 2001-03-28
JP4485060B2 (ja) 2010-06-16
NO330234B1 (no) 2011-03-07
EP1117420A1 (en) 2001-07-25
EE04872B1 (et) 2007-08-15
CA2344470A1 (en) 2000-04-06
HK1042047B (zh) 2005-12-16
TR200100887T2 (tr) 2001-10-22
CZ302343B6 (cs) 2011-03-23
HUP0103649A2 (hu) 2002-02-28
NZ510446A (en) 2003-01-31
DK1117420T3 (da) 2002-09-16
CN1324241A (zh) 2001-11-28
PT1117420E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
ATE288410T1 (de) Vitamin d-analoga
IS5046A (is) Lyfjasamsetningar
ID27415A (id) Komposisi farmaseutik
IL164890A0 (en) Thiophene amidine derivatives and pharmaceutical compositions containing the same
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
EE03664B1 (et) Farmatseutilised aerosoolkompositsioonid
ID18352A (id) Komposisi-komposisi farmasi
ATE321784T1 (de) Pthrp analogen
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
PT1239832E (pt) Composicoes farmaceuticas
EE9900260A (et) Ravimkompositsioonid külmkuivatamiseks
PT969815E (pt) Composicoes farmaceuticas
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
DE69827947D1 (de) Rapamycin-formulierungen zur oralen verabreichung
ID30032A (id) Formulasi farmasi
FI4488U1 (fi) Farmaseuttinen koostumus
PT941100E (pt) Composicoes farmaceuticas
ID28650A (id) KOMPOSISI FARMASI BERDASARKAN PADA α-SIKLODEKSTRIN UNTUK PENGGUNAAN SECARA DIMAKAN DARI ANALOG LH-RH
EE200000330A (et) Farmatseutilised kompositsioonid
AR025867A1 (es) Formulacion portasdora farmaceutica
EE200000459A (et) Farmatseutilised kompositsioonid